LTR Pharma Limited (AU:LTP) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
LTR Pharma Limited has requested a trading halt on its securities ahead of a significant announcement regarding a capital raise. The halt will remain in place until either the announcement is made or trading resumes on December 10, 2024. This move could signal potential growth opportunities for the company, which is focused on innovative treatments for men’s health.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.